Shanghai Shyndec Pharmaceutical Co.,Ltd.’s Net Profit Dropped 24.5% in First Three Quarters of 2022

Shanghai Shyndec Pharmaceutical Co.,Ltd. (上海现代制药股份有限公司) (600420.SH) reported a net profit of 604.2 million yuan in the first three quarters of 2022, down 24.5% year-on-year.

Meanwhile, the company posted 9.7 billion yuan in revenue, down 9.3% year-on-year.

At the end of the reporting period, it had 18.5 billion yuan in total assets and 7.8 billion yuan in total liabilities, with a liability-to-asset ratio of 42.1%.